Is LDL-C passed its prime? The emerging role of Non-HDL, LDL-P, and ApoB in CHD risk assessment

被引：17
|
作者：
Davidson, Michael H. [1 ]
机构：
[1] Univ Chicago, Pritzker Sch Med, Chicago, IL 60654 USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2008年 / 28卷 / 09期
关键词：
D O I：
10.1161/ATVBAHA.108.172718
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1582 / 1583
页数：2
相关论文
共 50 条
  • [1] Navigating Lipid Discrepancies: Implications for Cardiovascular Risk With LDL, Non-HDL, LDL-P, and ApoB
    Hassan, Sharjeel
    Triffon, Douglas W.
    CIRCULATION, 2024, 149
  • [2] UNLOCKING THE LIPID PUZZLE: DECIPHERING DISCORDANCE AMONG LDL, NON-HDL, LDL-P, AND APOB VALUES AND THEIR IMPACT ON CARDIOVASCULAR RISK ASSESSMENT
    Hassan, Sharjeel
    Triffon, Douglas W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1849 - 1849
  • [3] Risk stratification: ApoB and non-HDL better than LDL
    Lichert, Frank
    AKTUELLE KARDIOLOGIE, 2021, 10 (04) : 290 - 290
  • [4] ApoB and Non-HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk
    Johannesen, Camilla D. L.
    Mortensen, Martin B.
    Langsted, Anne
    Nordestgaard, Borge G.
    ANNALS OF NEUROLOGY, 2022, 92 (03) : 379 - 389
  • [5] The clinical utility of apoB versus LDL-C/non-HDL-C
    Kohli-Lynch, Ciaran N.
    Thanassoulis, George
    Moran, Andrew E.
    Sniderman, Allan D.
    CLINICA CHIMICA ACTA, 2020, 508 : 103 - 108
  • [6] ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease
    Sniderman, Allan D.
    CLINICAL CHEMISTRY, 2021, 67 (11) : 1440 - 1442
  • [7] The SANDS Trial: Does Aggressive Lowering of LDL-C and Non-HDL-C in Diabetes Decrease the Plasma ApoB and LDL-C Particle Number?
    Howard, Barbara V.
    Devereux, Richard B.
    Fleg, Jerome L.
    Howard, Wm. James
    Mete, Mihriye
    Otvos, James D.
    Ratner, Robert E.
    Roman, Mary J.
    Russell, Marie
    Umans, Jason G.
    Weissman, Neil J.
    CIRCULATION, 2008, 118 (18) : S1136 - S1136
  • [8] RELATIONSHIPS BETWEEN LDL-C, ApoB AND NON-HDL-C WITH hsCRP IN HYPERCHOLESTEROLEMIC PATIENTS AT RISK FOR CARDIOVASCULAR DISEASE
    O'Keefe, J.
    Abuannadi, M.
    Lin, J.
    Shah, A.
    Neff, D.
    Tomassini, J. E.
    Tershakovec, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 112 - 112
  • [9] ApoB triumphs once more over LDL-C and non-HDL-C in risk prediction: ready for guidelines?
    Mortensen, Martin Bodtker
    EUROPEAN HEART JOURNAL, 2024,
  • [10] Non-HDL cholesterol, ApoB and LDL particle concentration in coronary heart disease risk prediction and treatment
    Orringer, Carl E.
    CLINICAL LIPIDOLOGY, 2013, 8 (01) : 69 - 79
12345